Background: The ideal dose and specific prothrombin complex concentrate (PCC) for warfarin reversal is unknown.
Objective: To evaluate the reduction in international normalized ratio (INR) of 3 different PCC dosing regimens: fixed-dose activated 4-factor PCC (aPCC), fixed-dose 4-factor PCC (4PCC), and standard-dose 4PCC.
Methods: This was a multicenter retrospective cohort review.